Literature DB >> 2572535

Apolipoprotein (apo) E genotypes by polymerase chain reaction and allele-specific oligonucleotide probes: no detectable linkage disequilibrium between apo E and apo CII.

R S Houlston1, C Snowden, F Green, K G Alberti, S E Humphries.   

Abstract

Allelic sequence variation in the apolipoprotein (apo) E gene has been analysed by means of synthetic oligonucleotide probes that detect single base pair substitutions in the codons for amino acid positions 112 and 158, substitutions that are responsible for the common isoforms. Use of the polymerase chain reaction procedure to amplify a sequence of 330 base pairs of the human apo E gene has permitted the development of a robust method for apo E genotyping. This technique has been used to determine the apo E genotype in 95 individuals in whom the genotype for an apo CII TaqI restriction fragment length polymorphism has also been determined. No strong linkage disequilibrium between the two gene loci was detected. This suggests that the metabolic effects of variation in the apo E and apo CII genes, as detected by the polymorphisms used here, would operate in a statistically independent manner.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2572535     DOI: 10.1007/BF00291382

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  28 in total

1.  Characterization and quantitation of the apolipoproteins from human chyle chylomicrons.

Authors:  G Kostner; A Holasek
Journal:  Biochemistry       Date:  1972-03-28       Impact factor: 3.162

2.  A specific apoprotein activator for lipoprotein lipase.

Authors:  J C LaRosa; R I Levy; P Herbert; S E Lux; D S Fredrickson
Journal:  Biochem Biophys Res Commun       Date:  1970-10-09       Impact factor: 3.575

3.  The isolation and characterization of cDNA clones for human apolipoprotein CII.

Authors:  O Myklebost; B Williamson; A F Markham; S R Myklebost; J Rogers; D E Woods; S E Humphries
Journal:  J Biol Chem       Date:  1984-04-10       Impact factor: 5.157

4.  Human apolipoprotein E. The complete amino acid sequence.

Authors:  S C Rall; K H Weisgraber; R W Mahley
Journal:  J Biol Chem       Date:  1982-04-25       Impact factor: 5.157

5.  Primary structure of very low density apolipoprotein C-II of human plasma.

Authors:  R L Jackson; H N Baker; E B Gilliam; A M Gotto
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

6.  The locus for apolipoprotein E (apoE) is linked to the complement component C3 (C3) locus on chromosome 19 in man.

Authors:  B Olaisen; P Teisberg; T Gedde-Dahl
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

7.  Identification of apolipoprotein E polymorphism by using synthetic oligonucleotides.

Authors:  H J Smeets; J Poddighe; P M Stuyt; A F Stalenhoef; H H Ropers; B Wieringa
Journal:  J Lipid Res       Date:  1988-09       Impact factor: 5.922

8.  A common restriction fragment length polymorphism of the human apolipoprotein E gene and its relationship to type III hyperlipidaemia.

Authors:  E C Klasen; P J Talmud; L Havekes; E de Wit; E van der Kooij-Meijs; M Smit; G Hansson; S E Humphries
Journal:  Hum Genet       Date:  1987-03       Impact factor: 4.132

9.  The gene for apolipoprotein C-II is closely linked to the gene for apolipo-protein E on chromosome 19.

Authors:  S E Humphries; K Berg; L Gill; A M Cumming; F W Robertson; A F Stalenhoef; R Williamson; A L Børresen
Journal:  Clin Genet       Date:  1984-11       Impact factor: 4.438

Review 10.  Apolipoprotein E polymorphism and atherosclerosis.

Authors:  J Davignon; R E Gregg; C F Sing
Journal:  Arteriosclerosis       Date:  1988 Jan-Feb
View more
  7 in total

1.  A multilocus genotyping assay for candidate markers of cardiovascular disease risk.

Authors:  S Cheng; M A Grow; C Pallaud; W Klitz; H A Erlich; S Visvikis; J J Chen; C R Pullinger; M J Malloy; G Siest; J P Kane
Journal:  Genome Res       Date:  1999-10       Impact factor: 9.043

2.  Apolipoprotein e4 allele and endothelium-dependent arterial dilation in Type 2 diabetes mellitus without angiopathy.

Authors:  X Guangda; W Yuhua
Journal:  Diabetologia       Date:  2003-03-25       Impact factor: 10.122

3.  The production of PCR products with 5' single-stranded tails using primers that incorporate novel phosphoramidite intermediates.

Authors:  C R Newton; D Holland; L E Heptinstall; I Hodgson; M D Edge; A F Markham; M J McLean
Journal:  Nucleic Acids Res       Date:  1993-03-11       Impact factor: 16.971

Review 4.  Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E.

Authors:  N Nathoo; R Chetty; J R van Dellen; G H Barnett
Journal:  Mol Pathol       Date:  2003-06

5.  The apolipoprotein E/CI/CII gene cluster and late-onset Alzheimer disease.

Authors:  C E Yu; H Payami; J M Olson; M Boehnke; E M Wijsman; H T Orr; W A Kukull; K A Goddard; E Nemens; J A White
Journal:  Am J Hum Genet       Date:  1994-04       Impact factor: 11.025

6.  Confirmation of association between the e4 allele of apolipoprotein E and Alzheimer's disease.

Authors:  M Liddell; J Williams; A Bayer; F Kaiser; M Owen
Journal:  J Med Genet       Date:  1994-03       Impact factor: 6.318

7.  Polymorphisms of the apolipoprotein B and E genes and their relationship to plasma lipid variables in healthy Chinese men.

Authors:  A E Evans; W Zhang; J F Moreel; J M Bard; S Ricard; O Poirier; L Tiret; J C Fruchart; F Cambien
Journal:  Hum Genet       Date:  1993-09       Impact factor: 4.132

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.